Rapt Therapeutics Inc. buy Warner
Start price
23.12.24
/
0%
€1.52
Target price
23.12.25
-
Performance (%)
-41.12%
Price
16.06.25
€0.90
Summary
This prediction is currently active. The BUY prediction by Warner for Rapt Therapeutics Inc. is performing very badly with a performance of -41.12%. This prediction currently runs until 23.12.25. The prediction end date can be changed by Warner at any time. This prediction was marked as speculative and is excluded from Warner's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rapt Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to Warner what are the pros and cons of Rapt Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Cons
Little innovation
Comments by Warner for this prediction
In the thread Rapt Therapeutics Inc. diskutieren
Buy Rapt Therapeutics Inc.